LeoJanBastiaensMD

PubMed

• 4 citations
  Treatment of Adult ADHD without Stimulants: Effectiveness in A Dually Diagnosed Correctional Population
  Leo Bastiaens, Olivia Scott, James Galus> ;The Psychiatric Quarterly. 2019 Mar 1
• 12 citations
  Comparison of the Adult ADHD Self Report Scale Screener for DSM-IV and DSM-5 in a Dually Diagnosed Correctional Population.
  Leo Bastiaens, James Galus> ;The Psychiatric Quarterly. 2018 Jun 1
• 20 citations
  The DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure as a Screening Tool
  Leo Bastiaens, James Galus> ;The Psychiatric Quarterly. 2018 Mar 1
• 48 citations
  Abuse of Gabapentin is Associated with Opioid Addiction.
  Leo Bastiaens, James Galus, Cherise Mazur> ;The Psychiatric Quarterly. 2016 Feb 18
• 6 citations
  The 12 item W.H.O.D.A.S. as primary self report outcome measure in a correctional community treatment center for dually diagnosed patients.
  Leo Bastiaens, James Galus, Michael Goodlin> ;The Psychiatric Quarterly. 2015 Jun 1
• 5 citations
  Improvement in Global Psychopathology Increases Quality of Life During Treatment of ADHD with Atomoxetine or Stimulants
  Leo Bastiaens> ;The Psychiatric Quarterly. 2011 Mar 25
• An unusual case of insulinoma.
  Leo Bastiaens> ;The American Surgeon. 2008 Dec 1
• 3 citations
  Severely Mood-disordered Youth Respond Less Well to Treatment in a Community Clinic than Youth with Bipolar Disorder.
  Leo Bastiaens, Jesse Bastiaens> ;Psychiatry. 2008 Oct 1
• 16 citations
  A non-randomized, open study with aripiprazole and ziprasidone for the treatment of aggressive behavior in youth in a community clinic.
  Leo Bastiaens> ;Community Mental Health Journal. 2009 Feb 1
• 17 citations
  Both Atomoxetine and Stimulants Improve Quality of Life in an ADHD Population Treated in a Community Clinic
  Leo Bastiaens> ;The Psychiatric Quarterly. 2008 Mar 8
• 5 citations
  Effectiveness and tolerability of atomoxetine in a real-world ADHD population: nonrandomized comparison with stimulants.
  Leo Bastiaens> ;Psychiatry. 2007 Dec 1
• 3 citations
  Quality of life of children and adolescents: during psychiatric treatment in a community mental health setting.
  Leo Bastiaens, Cathy Dello Stritto> ;Psychiatry. 2005 Aug 1
• 1 citations
  Adolescents' response to antidepressant treatment in a community mental health center
  Leo Bastiaens> ;Community Mental Health Journal. 2005 Feb 1
• 5 citations
  Response to antidepressant treatment in a community mental health center.
  Leo Bastiaens> ;Community Mental Health Journal. 2004 Dec 1
• 14 citations
  The RAFFT as a screening tool for adult substance use disorders.
  Leo Bastiaens, Kathleen Riccardi, Duru Sakhrani> ;The American Journal of Drug and Alcohol Abuse. 2002 Nov 27
• 1 citations
  Trauma and PTSD among substance-abusing patients.
  Leo Bastiaens, Jacob Kendrick> ;Psychiatric Services. 2002 May 1
• 2 citations
  Medication samples and drug compliance.
  Leo Bastiaens, Salim Chowdhury, Larry Gitelman> ;Psychiatric Services. 2000 Jun 1
• 16 citations
  The RAFFT as a Screening Tool for Adolescent Substance Use Disorders
  Leo Bastiaens, Gerard Francis, R N Karen Lewis> ;The American Journal on Addictions. 2000 Jan 1
• 5 citations
  Pediatric Psychopharmacology in a Capitated Managed Care System: How Do Patients Fare?
  Leo Bastiaens> ;Journal of Child and Adolescent Psychopharmacology. 1998 Jan 1
• 7 citations
  The impact of an intensive educational program on knowledge, attitudes, and side effects of psychotropic medications among adolescent inpatients.
  Leo Bastiaens> ;Journal of Child and Adolescent Psychopharmacology. 1992 Jan 1
• 5 citations
  Knowledge, Expectations, and Attitudes of Hospitalized Children and Adolescents in Psychopharmacological Treatment
  Leo Bastiaens> ;Journal of Child and Adolescent Psychopharmacology. 1992 Jan 1
• Change in subtype presentation in schizophrenics.
  P.D. Harvey, Michael H. Davidson, Kenneth L. Davis, Leo Bastiaens> ;Comprehensive Psychiatry. 1989 Jan 1
• 3 citations
  Growth hormone response to edrophonium in patients with Alzheimer's disease and normal control subjects.
  Michael Davidson, Bonnie M. Davis, Leo Bastiaens, J. M. Macaluso, Mosen Aryan, Theresa M. Ryan, Kenneth L. Davis> ;The American Journal of Psychiatry. 1988 Aug 1
• 6 citations
  Endocrine Changes in Alzheimer’s Disease
  Michael Davidson, Leo Bastiaens, Bonnie M. Davis, Mahendra B. Shah, Kenneth L. Davis> ;Endocrinology and Metabolism Clinics of North America. 1988 Mar 1
• 5 citations
  Endocrine changes in Alzheimer's disease.
  Michael Davidson, Leo Bastiaens, Bonnie M. Davis, Mahendra B. Shah, Kenneth L. Davis> ;Neurologic Clinics. 1988 Feb 1
• Join now to see all

Journal Articles

• The 12 item WHODAS as primary self-report outcome measure in a correctional community treatment center for dually diagnosed patients  
  Bastiaens L, Psychiatric Quarterly, 1/1/2014
• Better psychiatric documentation: From SOAP to PROMISE  
  Bastiaens L, Current Psychiatry, 1/1/2013
• Improvement in global psychopathology increases quality of life during treatment of ADHD with Atomoxetine or stimulants  
  Bastiaens L, Psychiatric Quarterly, 1/1/2011
• Measurement-based practice may not be effective in the community care of patients with schizophrenia  
  Bastiaens L, Primary Psychiatry, 1/1/2010
• A non-randomized, open study with Aripiprazole and Ziprasidone for the treatment of aggressive behavior in youth in a community clinic  
  Bastiaens L, Community Mental Health Journal, 1/1/2009
• Pharmacotherapy of bipolar disorder: focus on aripiprazole  
  Bastiaens L, Clinical Medicine: Therapeutics, 1/1/2009
• Both atomoxetine and stimulants improve quality of life in an ADHD population treated in a community clinic  
  Bastiaens L, Psychiatric Quarterly, 1/1/2008
• Effectiveness and tolerability of atomoxetine in a real-world ADHD population: non-randomized comparison with stimulants  
  Bastiaens L, Psychiatry, 1/1/2007
• Antidepressants and new-onset suicidality in pediatric patients treated in a community mental health center  
  Bastiaens L, Primary Psychiatry, 1/1/2006
• Youth aggression: economic impact, causes, prevention, and treatment  
  Bastiaens L, Psychiatric Times, 1/1/2006
• Quality of life of children and adolescents during psychiatric treatment in a community mental health setting  
  Bastiaens L, Dello Stritto C, Psychiatry, 1/1/2005
• Adolescents’ response to antidepressant treatment in a community mental health center  
  Bastiaens L, Community Mental Health Journal, 1/1/2005
• Does residential treatment impact pharmacotherapy in children and adolescents?  
  Bastiaens L, Psychiatric Times, 1/1/2004
• Trauma and PTSD among substance-abusing patients  
  Bastiaens L, Kendrick J, Psychiatric Services, 1/1/2002
• The RAFFT as a screening instrument for adolescent substance use disorders  
  Bastiaens L, Francis G, Lewis K, Am. J. Addictions, 1/1/2000
• Attention Deficit Hyperactivity Disorder's co-morbidity is often overlooked  
  Bastiaens L, St. Francis Journal of Medicine, 1/1/1999
• Pediatric psychopharmacology in a capitated managed care system: How do patients fare?  
  Bastiaens L, J.Child Adol. Psychopharm, 1/1/1998
• Adolescent suicide: a growing problem  
  Bastiaens L, St. Francis Journal of Medicine, 1/1/1997
• Compliance with pharmacotherapy in adolescents: effects of patients' and parents' knowledge and attitudes towards treatment  
  Bastiaens L, J. Child Adol. Psychopharm, 1/1/1995
• A manual of psychiatric medications for teenagers  
  Bastiaens L, Bastiaens DK, J. Child Adol. Psychopharm, 1/1/1993
• Knowledge, expectations and attitudes of hospitalized children and adolescents in psychopharmacological treatment  
  Bastiaens L, J. Child Adol. Psychopharm, 1/1/1992
• A case of substantial subtype variation in schizophrenia: associations with medications and overall BPRS scores  
  Harvey PA, Bastiaens L, Davidson M, Davis KL, Comprehensive Psychiatry, 1/1/1989
• Growth hormone response to Edrophonium in patients with Alzheimer's disease and normal controls  
  Davidson M, Davis BM, Bastiaens L, Macaluso J, Aryan M,Ryan T, Davis KL, Am J Psychiatry, 1/1/1988
• Orientation discrimination in human visual perception: visual versus vestibular factors  
  Orban G, Vandenbussche E, Bastiaens L, Marcelis L, Archives Internationale de Physiologie et de Biochimie, 2/1/1981
• Join now to see all

Books/Book Chapters

• The Depressed Child and Adolescent: Developmental and Clinical Perspectives 
  Chapter: The psychotherapeutic management of major depressive and dysthymic disorders in childhood and adolescence: issues and prospects 
  Kovacs M, Bastiaens LEditors: Goodyer IM.Cambridge University Press, United Kingdom1995
• Progress in Catecholamine Research, Part C: Clinical Aspects 
  Chapter: Clinical studies of plasma homovanillic acid 
  Davidson M, Freed L, Bastiaens L, Darcera C, Kaminski R, Davis KLAlan R. Liss, Inc., New York1988
• Endocrinology and Metabolism Clinics of North America 
  Chapter: Endocrine changes in Alzheimer's disease 
  Davidson M, Bastiaens L, Davis BM, Shah M, Davis KL1988

Abstracts/Posters

• Use of the WHODAS in a correctional community treatment center
  Bastiaens L, World Congress of Psychiatry, 1/1/2014
• Improvement in global psychopathology increases quality of life during treatment of ADHD with Atomoxetine or stimulants
  Bastiaens L, World Congress of Psychiatry, 1/1/2011
• Severely mood-disordered youth respond less well to treatment in a community clinic than youth with bipolar disorder
  Bastiaens L, European Congress of Psychiatry, 1/1/2009
• Effectiveness and tolerability of atomoxetine in a real-world ADHD population: non-randomized comparison with stimulants
  Bastiaens L, World Congress of Psychiatry, 1/1/2008
• A non-randomized, open study with Aripiprazole and Ziprasidone for the treatment of aggressive behavior in youth in a community clinic
  Bastiaens L, American Psychiatric Association, 1/1/2006
• Quality of life of children and adolescents during psychiatric treatment in a community mental health setting
  Bastiaens L, 158th annual meeting of the American Psychiatric Association, 1/1/2005
• Pediatric experience with aripiprazole
  Bastiaens L, Bastiaens D, 158th annual meeting of the American Psychiatric Association, 1/1/2005
• Validity and reliability of the Health And Life Functioning Scale
  Bastiaens L, Dello Stritto C, 51st annual meeting of the American Academy of Child and Adolescent Psychiatry, 1/1/2004
• Adolescents’ response to antidepressant treatment in a community mental health center
  Bastiaens L, American Academy of Child and Adolescent Psychiatry, 1/1/2003
• Trauma and PTSD among substance-abusing patients
  Bastiaens L, Kendrick J, 154th annual meeting of the American Psychiatric Association, 1/1/2001
• Cognitive - behavioral treatment of suicidal adolescents
  Bastiaens L, XI World Congress of Psychiatry and Current Opinion in Psychiatry, 8/1/1999
• Sample medications enhance initial compliance
  Bastiaens L, Chowdhury S, Gitelman L, 152nd annual meeting of the American Psychiatric Association, 1/1/1999
• The RAFFT as a screening instrument for adolescent substance use disorders
  Bastiaens L, 45th annual meeting of the American Academy of Child and adolescent Psychiatry, 1/1/1998
• Does the adolescent symptom inventory correlate with level of care?
  Bastiaens L, Bastiaens D, 45th annual meeting of the American Academy of Child and Adolescent Psychiatry, 1/1/1998
• Compliance with pharmacotherapy in adolescents: effects of patients' and parents' knowledge and attitudes towards treatment
  Bastiaens L, 40th annual meeting of the American Academy of Child and Adolescent Psychiatry, 1/1/1993
• The impact of an intensive educational program on knowledge, attitudes and side effects of psychotropic medications among adolescent inpatients
  Bastiaens L, 39th annual meeting of the American Academy of Child and Adolescent Psychiatry, 1/1/1992
• Knowledge, expectations and attitudes of hospitalized children and adolescents in psychopharmacological treatment
  Bastiaens L, 144th annual meeting of the American Psychiatric Association, 1/1/1991
• Join now to see all

Lectures

• Treating pediatric patients with bipolar disorder 
  4/23/2009
• Winnie the Pooh and Mood Disorders, too 
  4/17/2003
• PTSD in substance abusers 
  2/21/2003
• Treatment of agitation in the emergency room 
  12/3/2002
• Treatment of acute psychosis 
  12/21/2000
• Sleep and depression 
  9/15/2000
• Cognitive strategies in Mental Health 
  9/7/2000
• Attention Deficit Disorder 
  5/19/2000
• Do kids get depressed? 
  3/29/2000
• Childhood depression 
  12/7/1999
• Mood disorders in childhood 
  11/9/1999
• Winnie the Pooh and Mood Disorders, too; Psychopharmacology in Managed Care 
  10/8/1999
• Issues in the diagnosis and treatment of depression 
  9/7/1999
• Treatment of Depressive Disorders 
  5/4/1999
• Improving the management of depression 
  2/10/1999
• Psychotherapeutic management of depression in children and adolescents 
  9/19/1996
• Psychotherapeutic interventions for children and adolescents with major depression and dysthymia 
  1/26/1995
• Mood disorders across the life span 
  11/18/1993
• Cognitive-behavioral therapy with teenagers and their families 
  8/12/1993
• Pharmacotherapy for suicidal teenagers 
  4/26/1993
• Join now to see all